Omnicell Investor Presentation Deck

2 Leader in Large and Growing Segments Omnicell is growing its leadership position across a potential $90 Billion+ TAM Estimated TAM Opportunity¹ $22 Billion Retail $19 Billion Specialty Pharmacy Services $90 Billion+ TOTAL TAM $19 Billion Point of Care $32 Billion Central Pharmacy © 2023 Omnicell, Inc. 1. Represents estimated cumulative TAM over 10 years as of 5/31/2022 and includes the United States, UK&I, Germany, France, Spain, Kingdom of Saudi Arabia and Australia/New Zealand. 8

View entire presentation